Relmada Therapeutics (RLMD) Shares Issued (2012 - 2026)
Relmada Therapeutics (RLMD) reported Shares Issued of $160.0 million for Q1 2026, up 64743.75% on a QoQ basis from $246747.0 in Q1 2024.
Relmada Therapeutics (RLMD) has 10 years of Shares Issued data on file, last reported at $160.0 million in Q1 2026.
- Quarterly Shares Issued changed N/A year-over-year to $160.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $160.0 million (changed N/A YoY) and the FY2025 annual result came in at $93.6 million, up 37848.92% from the prior year.
- Shares Issued grew to $160.0 million in Q1 2026 per RLMD's latest filing, from $246747.0 in the prior quarter.
- Across five years, Shares Issued topped out at $160.0 million in Q1 2026 and bottomed at -$42.0 million in Q3 2022.
- The 3-year median for Shares Issued is $430404.5 (2022), against an average of $26.9 million.
- Peak annual rise in Shares Issued reached 92.88% in 2022, while the deepest fall reached 99925.89% in 2022.
- Tracing RLMD's Shares Issued over 3 years: stood at $560803.0 in 2022, then sank by 56.0% to $246747.0 in 2024, then jumped by 64743.75% to $160.0 million in 2026.
- Per Business Quant, the three latest RLMD Shares Issued figures stand at $160.0 million (Q1 2026), $246747.0 (Q1 2024), and $560803.0 (Q4 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Relmada Therapeutics | 595.35 Mn | 595.35 Mn | - | 160.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 160.00 Mn |
| Mar 31, 2026 | 160.00 Mn |
| Mar 31, 2024 | 246,747.00 |
| Mar 31, 2024 | 246,747.00 |
| Dec 31, 2022 | 560,803.00 |
| Dec 31, 2022 | 560,803.00 |
| Sep 30, 2022 | -42.02 Mn |
| Sep 30, 2022 | -42.02 Mn |
| Jun 30, 2022 | 42.43 Mn |
| Jun 30, 2022 | 42.43 Mn |
| Mar 31, 2022 | 300,006.00 |
| Mar 31, 2022 | 300,006.00 |
| Dec 31, 2021 | 161.23 Mn |
| Dec 31, 2021 | 161.23 Mn |
| Sep 30, 2021 | -42,014.00 |
| Sep 30, 2021 | -42,014.00 |
| Jun 30, 2021 | 22.00 Mn |
| Jun 30, 2021 | 22.00 Mn |
| Mar 31, 2021 | 1.46 Mn |
| Mar 31, 2021 | 1.46 Mn |
| Dec 31, 2020 | 7.42 Mn |
| Dec 31, 2020 | 7.42 Mn |
| Sep 30, 2020 | -19.22 Mn |
| Sep 30, 2020 | -19.22 Mn |
| Jun 30, 2020 | 16.81 Mn |
| Jun 30, 2020 | 16.81 Mn |
| Mar 31, 2020 | 3.04 Mn |
| Mar 31, 2020 | 3.04 Mn |
| Sep 30, 2019 | 825,749.00 |
| Sep 30, 2019 | 825,749.00 |
| Jun 30, 2019 | 12.58 Mn |
| Jun 30, 2019 | 12.58 Mn |
| Mar 31, 2019 | 1.73 Mn |
| Mar 31, 2019 | 1.73 Mn |
| Dec 31, 2018 | -8.23 Mn |
| Dec 31, 2018 | -8.23 Mn |
| Sep 30, 2018 | 404,500.00 |
| Sep 30, 2018 | 404,500.00 |
| Jun 30, 2015 | -19,201.00 |
| Jun 30, 2015 | -19,201.00 |
| Mar 31, 2015 | 10,000.00 |
| Mar 31, 2015 | 10,000.00 |
| Dec 31, 2014 | 9.13 Mn |
| Dec 31, 2014 | 9.13 Mn |
| Sep 30, 2014 | 4.31 Mn |
| Sep 30, 2014 | 4.31 Mn |
| Jun 30, 2014 | 2.00 Mn |
| Jun 30, 2014 | 2.00 Mn |
| May 31, 2012 | 9,500.00 |
| May 31, 2012 | 9,500.00 |